Cervical Screening-1 Conventional PAP & HPV-DNA Test51+ booked in last 3 days
Under this a conventional PAP smear and Human Papilloma Virus detection and typing are carried out to identify patients at risk of cervical cancer.
Frequently Asked Questions
This test allows laboratory to identify patients at risk of developing cervical cancer by Conventional PAP and detection of Human papilloma virus.
All women between 25 yrs to 65 yrs should undergo cervical cancer screening.
As per American Cancer Society all women between 25 yrs to 65 yrs should undergo cervical cancer screening. Conventional PAP smear is reported & HPV-DNA is detected with FDA approved HPV digene assay. All HPV positive cases undergo genotyping to identify involement genotypes which are associated with high risk of cervical cancer.
Ratings & Reviews (0)
Metropolis has a team of 200 senior pathologists and over 2000 technicians delivering diagnostic solutions in the areas of routine, semi specialty and super specialty domains like Oncology, Neurology, Gynaecology, Nephrology and many more.
We offer a comprehensive range of 4000+ clinical laboratory tests and profiles, which are used for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease.